VCEL

Vericel Corporation NASDAQ

Healthcare ·Biotechnology ·US · vcel.com

$36.49

Mkt Cap $1.9B

52w Low $28.95 44.3% of range 52w High $45.97

50d MA $34.07 200d MA $35.67

P/E (TTM) 107.8x

EV/EBITDA 60.1x

P/B 5.1x

Debt/Equity 0.3x

ROE 4.7%

P/FCF 73.6x

RSI (14) —

ATR (14) —

Beta 1.21

50d MA $34.07

200d MA $35.67

Avg Volume 592.6K

About

Vericel Corporation, a commercial-stage biopharmaceutical company, engages in the research, development, manufacture, and distribution of cellular therapies for sports medicine and severe burn care markets in the United States. The company markets autologous cell therapy products comprising MACI, an autologous cellularized scaffold product for the repair of symptomatic, and single or multiple full…

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	Guide ▲★
Feb 26, 2026	AMC	0.45	0.45	+0.0%	37.68	-2.7%	-5.3%	-6.2%	-8.7%	-7.2%	-9.8%	—
Nov 6, 2025	AMC	-0.02	0.10	+600.0%	38.75	+0.9%	+0.5%	+0.6%	+5.9%	+4.4%	+2.8%	—
Jul 31, 2025	AMC	-0.04	-0.01	+75.0%	34.94	-1.6%	+2.0%	+7.6%	+5.4%	+3.9%	+3.5%	—
May 8, 2025	AMC	-0.09	-0.23	-155.6%	41.87	-0.2%	-0.3%	+1.9%	+4.2%	+1.0%	-0.9%	—
Feb 27, 2025	AMC	0.31	0.38	+22.6%	49.62	+0.0%	+3.4%	-0.2%	+3.1%	+3.8%	-1.7%	—
Nov 7, 2024	AMC	-0.05	-0.02	+60.0%	50.03	-1.0%	+7.9%	+13.5%	+11.7%	+10.9%	+5.4%	—
Aug 1, 2024	AMC	-0.10	-0.10	+0.0%	47.52	-1.2%	+0.2%	-3.5%	-1.6%	-4.7%	-2.7%	—
May 8, 2024	AMC	-0.11	-0.08	+27.3%	47.69	+0.3%	+2.0%	+0.9%	+1.7%	+1.8%	+3.6%	—
Feb 29, 2024	AMC	0.17	0.26	+52.9%	45.68	+1.6%	-2.1%	-2.0%	-2.7%	-1.1%	-1.9%	—
Nov 8, 2023	AMC	-0.13	-0.08	+38.5%	35.27	+0.3%	-8.1%	-3.9%	-3.7%	+4.2%	+2.2%	—
Aug 2, 2023	AMC	-0.13	-0.11	+15.4%	34.63	+0.9%	-7.7%	-7.6%	-7.9%	-5.3%	-7.1%	—
May 10, 2023	AMC	-0.13	-0.16	-23.1%	34.19	+0.7%	-3.5%	-4.1%	-1.3%	-3.3%	-3.9%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
Apr 15	Truist	Maintains	Buy → Buy	—	$35.14	$34.89	-0.7%	+0.7%	-3.9%	+1.5%	+1.9%	-4.2%
Feb 27	HC Wainwright & Co.	Maintains	Buy → Buy	—	$37.68	$36.66	-2.7%	-5.3%	-6.2%	-8.7%	-7.2%	-9.8%
Dec 18	Truist	Maintains	Buy → Buy	—	$36.40	$36.40	+0.0%	-0.7%	-1.0%	+2.7%	+2.7%	+3.2%
Nov 10	Truist	Maintains	Buy → Buy	—	$38.94	$39.71	+2.0%	+0.1%	+5.4%	+3.9%	+2.3%	+2.4%
Oct 15	Truist	Maintains	Buy → Buy	—	$34.64	$34.23	-1.2%	-3.0%	+0.3%	+2.0%	+4.0%	+5.2%
Sep 17	BTIG	Downgrade	Buy → Neutral	—	$33.23	$31.85	-4.2%	-9.7%	-4.2%	-4.7%	-4.3%	-6.1%
Aug 1	Canaccord Genuity	Maintains	Buy → Buy	—	$34.94	$34.38	-1.6%	+2.0%	+7.6%	+5.4%	+3.9%	+3.5%
Jun 16	Stephens & Co.	Maintains	Overweight → Overweight	—	$42.67	$43.03	+0.8%	-2.5%	-2.7%	-2.1%	-1.5%	-2.0%
May 22	Stephens & Co.	Maintains	Overweight → Overweight	—	$41.07	$40.74	-0.8%	+0.8%	-0.4%	+2.4%	+2.5%	+0.7%
Apr 11	Truist	Maintains	Buy → Buy	—	$41.90	$41.33	-1.4%	-1.6%	-1.6%	+0.3%	-2.6%	-1.6%
Mar 3	Truist	Maintains	Buy → Buy	—	$51.29	$51.20	-0.2%	-3.5%	-0.3%	+0.5%	-4.9%	-3.4%
Feb 28	HC Wainwright & Co.	Maintains	Buy → Buy	—	$49.62	$49.63	+0.0%	+3.4%	-0.2%	+3.1%	+3.8%	-1.7%
Feb 3	Canaccord Genuity	Maintains	Buy → Buy	—	$58.54	$58.25	-0.5%	+0.9%	+1.5%	+5.6%	+2.0%	-0.3%
Jan 15	Stephens & Co.	Maintains	Overweight → Overweight	—	$58.67	$55.09	-6.1%	-1.9%	-4.0%	+0.7%	+1.5%	-0.2%
Jan 15	HC Wainwright & Co.	Maintains	Buy → Buy	—	$58.67	$55.09	-6.1%	-1.9%	-4.0%	+0.7%	+1.5%	-0.2%
Dec 18	Truist	Maintains	Buy → Buy	—	$56.69	$57.07	+0.7%	-0.8%	-3.1%	-0.3%	+0.6%	+1.1%
Nov 26	BTIG	Maintains	Buy → Buy	—	$58.62	$58.40	-0.4%	+0.2%	-1.5%	-0.8%	+0.2%	-0.6%
Nov 19	Canaccord Genuity	Maintains	Buy → Buy	—	$52.89	$52.68	-0.4%	+5.6%	+8.3%	+7.2%	+11.8%	+10.8%
Nov 8	HC Wainwright & Co.	Maintains	Buy → Buy	—	$50.03	$49.54	-1.0%	+7.9%	+13.5%	+11.7%	+10.9%	+5.4%
Aug 27	TD Cowen	Maintains	Buy → Buy	—	$49.94	$49.85	-0.2%	+7.2%	+5.3%	+3.2%	+3.4%	-1.8%
Aug 2	Stephens & Co.	Maintains	Overweight → Overweight	—	$47.52	$46.97	-1.2%	+0.2%	-3.5%	-1.6%	-4.7%	-2.7%
Aug 2	HC Wainwright & Co.	Maintains	Buy → Buy	—	$47.52	$46.97	-1.2%	+0.2%	-3.5%	-1.6%	-4.7%	-2.7%
Jul 16	Truist	Maintains	Buy → Buy	—	$49.85	$50.66	+1.6%	+4.8%	+3.8%	+2.8%	+0.5%	+3.5%
Jul 15	BTIG	Maintains	Buy → Buy	—	$48.50	$48.63	+0.3%	+2.8%	+7.7%	+6.6%	+5.6%	+3.3%
May 9	HC Wainwright & Co.	Maintains	Buy → Buy	—	$47.69	$47.83	+0.3%	+2.0%	+0.9%	+1.7%	+1.8%	+3.6%
Mar 26	Truist	Maintains	Buy → Buy	—	$47.94	$48.13	+0.4%	+3.4%	+9.2%	+8.5%	+10.3%	+6.9%
Mar 1	HC Wainwright & Co.	Maintains	Buy → Buy	—	$45.68	$46.43	+1.6%	-2.1%	-2.0%	-2.7%	-1.1%	-1.9%
Mar 1	Truist	Maintains	Buy → Buy	—	$45.68	$46.43	+1.6%	-2.1%	-2.0%	-2.7%	-1.1%	-1.9%
Jan 25	Truist	Upgrade	Hold → Buy	—	$40.82	$43.41	+6.3%	+4.4%	+4.4%	+9.2%	+8.4%	+5.3%
Jan 16	HC Wainwright & Co.	Maintains	Buy → Buy	—	$38.24	$38.39	+0.4%	+2.5%	-1.1%	+2.4%	+3.7%	+9.9%
Nov 9	Truist	Maintains	Hold → Hold	—	$35.27	$35.39	+0.3%	-8.1%	-3.9%	-3.7%	+4.2%	+2.2%
Sep 21	Stephens & Co.	Maintains	Overweight → Overweight	—	$32.52	$33.26	+2.3%	+5.1%	+4.6%	+4.6%	+3.0%	+9.2%
Sep 21	Truist	Maintains	Hold → Hold	—	$32.52	$33.26	+2.3%	+5.1%	+4.6%	+4.6%	+3.0%	+9.2%
Sep 21	HC Wainwright & Co.	Maintains	Buy → Buy	—	$32.52	$33.26	+2.3%	+5.1%	+4.6%	+4.6%	+3.0%	+9.2%
Aug 8	BTIG	Upgrade	Neutral → Buy	—	$31.90	$33.22	+4.1%	+2.8%	+0.8%	-0.1%	-0.7%	+0.8%
Aug 3	HC Wainwright & Co.	Maintains	Buy → Buy	—	$34.63	$34.95	+0.9%	-7.7%	-7.6%	-7.9%	-5.3%	-7.1%
Aug 3	Truist	Maintains	Hold → Hold	—	$34.63	$34.95	+0.9%	-7.7%	-7.6%	-7.9%	-5.3%	-7.1%
Jul 19	Truist	Maintains	Hold → Hold	—	$38.87	$39.06	+0.5%	+1.0%	-1.5%	-0.4%	-1.2%	-3.8%
May 11	Stephens & Co.	Maintains	Overweight → Overweight	—	$34.19	$34.44	+0.7%	-3.5%	-4.1%	-1.3%	-3.3%	-3.9%
May 11	Truist	Maintains	Hold → Hold	—	$34.19	$34.44	+0.7%	-3.5%	-4.1%	-1.3%	-3.3%	-3.9%
Feb 27	Truist	Maintains	Hold → Hold	—	$30.50	$30.82	+1.0%	+0.6%	-0.3%	-1.7%	-0.9%	+2.7%
Jan 31	Truist	Maintains	Hold → Hold	—	$27.03	$27.03	+0.0%	+1.6%	+5.0%	+15.9%	+14.9%	+13.2%
Jan 27	HC Wainwright & Co.	Maintains	Buy → Buy	—	$27.85	$27.83	-0.1%	+2.4%	-2.9%	-1.4%	+1.9%	+12.5%
Jan 3	HC Wainwright & Co.	Maintains	Buy → Buy	—	$26.34	$26.60	+1.0%	-4.6%	-3.2%	-7.1%	-9.3%	-9.5%
Dec 20	Truist	Maintains	Hold → Hold	—	$22.84	$22.89	+0.2%	+4.5%	+8.1%	+6.9%	+4.3%	+3.1%
Nov 10	BTIG	Downgrade	Buy → Neutral	—	$17.65	$17.39	-1.5%	+27.0%	+34.8%	+30.8%	+31.9%	+27.0%
Nov 10	HC Wainwright & Co.	Maintains	Buy → Buy	—	$17.65	$17.39	-1.5%	+27.0%	+34.8%	+30.8%	+31.9%	+27.0%
Jul 18	BTIG	Maintains	Buy → Buy	—	$27.54	$27.74	+0.7%	-1.1%	+2.6%	+2.2%	+4.0%	+2.5%
Feb 25	SVB Leerink	Maintains	Outperform → Outperform	—	$38.88	$38.60	-0.7%	+0.9%	+6.0%	+4.6%	+11.3%	+4.9%
Dec 21	Truist	Maintains	Buy → Buy	—	$38.30	$38.39	+0.2%	+4.0%	+5.7%	+8.7%	+9.6%	+5.5%

Recent Filings

8-K

Vericel Corporation -- 8-K Filing

Vericel reported strong Q4 results with revenue and profit growth, completed key initiatives, and projects continued momentum with accelerating cash generation and high growth expectations for 2026.

Feb 26

Data updated apr 27, 2026 7:24am · Source: massive.com